Time	Events	Chairs & Speakers
13:00 - 13;20	Registration
13:20 - 13:30	Opening Remark	Yong Sang Song (Seoul National University)
Session 1 - Chair: Omer Kucuk (Winship Cancer Institute of Emory University)
13:30 - 13:50	Antitumor effects of antidyslipidemic statin agents for ovarian cancer	Daisuke Aoki (Keio University)
13:50 - 14:10	Identification of radioresistant protein biomarkers and signaling pathways for personalized prostate cancer therapy	Yong Li (University of New South Wales)
14:10 - 14:30	Botanicals in Precision Cancer Medicine	Omer Kucuk (Winship Cancer Institute of Emory University)
14:30 - 14:50	Coffee break
Session 2 - Chair: Ki Baik Hahm (CHA University)
14:50 - 15:10	Precision cancer medicine for gastric cancer prevention with cancer preventive kimchi	Ki Baik Hahm (CHA University)
15:10 - 15:30	Microbiome-based personalized medicine for ovarian cancer	Yoon-Keun Kim (MD healthcare)
15:30 - 15:50	Non-coding microRNA as a Biomarker of Disease Response in Metastatic Endometrial Carcinoma	Katherine Moxley (University of Oklahoma)
15:50 - 16:10	Coffee break
Session 3 - Chair: Malyn Chulasiri (Chiang Mai University)
16:10 - 16:30	Safety and efficacy of herbal formulary "N040" in advanced cervical cancer: a clinical trial phase 1b	Monthaka Teerachaisakul (Thai Traditional Medicine Research Institute)
16:30 - 16:50	Deciphering human B cell repertoire with next-generation sequencing technology	Junho Chung (Seoul Naitonal University)
16:50 - 17:10	Application of liquid biopsy and pharmacogenomics to realize cancer precision medicine	Hitoshi Zembutsu (Cancer Precision Medicine Center)
17:10 - 17:30	Coffee break
Session 4 - Chair: Woong-Yang Park(Samsung Genome Institute)
17:10 - 17:50	Stapled BIG3 helical peptide ERAP potentiates anti-tumor activity for breast cancer therapeutics	Toyomasa Katagiri (The University of Tokushima)
17:50 - 18:10	Genomic and molecular profiling of ovarian cancer for precision medicine	Yong Sang Song (Seoul National University)
18:10 - 18:30	Understanding tumor microenvironment by single cell analysis	Woong-Yang Park (Samsung Genome Institute)
18:30	Closing remark	Yong Sang Song (Seoul National University)

Time	Events	Chairs & Speakers
8:30 - 9:00	Registration
9:00 - 9:10	Opening Remark	Yong Sang Song (Seoul National University)
Session 5 - Chair: Marc Diederich (Seoul National University)
9:10 - 9:30	Cell stress and non-canonical cell death modalities triggered by epigenetically active compounds	Marc Diederich (Seoul National University)
9:30 - 9:50	Genomics & ImmunoGenomics Pathology of Diffuse-type Gastric Carcinoma	Shumpei lshikawa (Tokyo Medical and Dental University)
9:50 - 10:10	Targeting concerted signaling proteins for synergistic lethality by combinatorial therapy against cancer	Annie NY Cheung (The University of Hong Kong)
10:10 - 10:30	Avenanthramides Inhibits Inflammatory Pathways in Muscle Cell	Li Li Ji (University of Minnesota)
10:30 - 10:50	Coffee break
Session 6 - Chiar: Young-Joon Surh (Seoul National University)
10:50 - 11:10	Semaphorin signaling via MICAL3 induces symmetric cell division of breast cancer stem-like cells	Noriko Gotoh (Kanazawa University)
11:10 - 11:30	Curcumin inhibits proliferation, migration and growth of human colon cancer cells through direct interaction with SIRT1	Young-Joon Surh (Seoul National University)
11:30 - 11:50	Exosome-mediated ovarian cancer chemoresistance: an autocrine role of plasma gelsolin (pGSN)	Benjamin K. Tsang (University of Ottawa)
11:50 - 13:00	Lunch
Session 7 - Chair: Dae-Shik Suh (University of Ulsan)
13:00 - 13:20	Efficacy and functional study of Tetraarsenic oxide as an anti-cancer drug in cervical cancer cell lines and cervical cancer patient-derived xenograft mouse	Byoung-Gie Kim (Sungkyunkwan University)
13:20 - 13:40	Individualized treatment for ovarian disease control using PIPAC as neo adjuvant treatment	Marc Pocard (Universite Paris Diderot)
13:40 - 14:00	Considering precision medicine in the setting of systemic disease – missing puzzles	Koraljka Gall Troselj(Rudjer Boskovic Institute)
14:00 - 14:20	Coffee break
Session 8 - Chiar: Johji Inazawa (Tokyo Medical and Dental University)
14:20 - 14:40	Non-coding RNA Driven Oncogenesis in Breast and Ovarian cancers	Pradeep Chaluvalli Raghavan (University of Milwaukee)
14:40 - 15:00	Exploring novel cancer-related microRNAs and their diagnostic and therapeutic potentials in Precision Cancer Medicine (PCM)	Johji Inazawa (Tokyo Medical and Dental Univsersity))
15:00 - 15:20	Precision Oncology: The foundation of future cancer prevention and therapeutics	Zigang Dong (University of Minnesota)
15:20 - 15:40	Coffee break
Session 9 - Chair: Jae Yong Han (Seoul National University)
15:40 - 16:00	Identification of histology-specific expression of HOX genes and tailored strategy for overcoming the resistance to platinum in epithelial ovarian cancer	Yong Beom Kim (Seoul National University)
16:00 - 16:20	PGC-mediated genome modification for avian model development	Jae Yong Han (Seoul National University)
16:20 - 16:40	Case sharing of use of PARP-inhibitors in the clinic	Karen K.L. Chan (The University of Hong Kong)
16:40 - 17:00	Coffee break
Session 10 - Chair: Danny N. Dhanasekaran (University of Oklahoma)
17:00 - 17:20	Mechanism of nitric oxide's in poor prognosis of breast cancer	David Wink (National Cancer Institute)
17:20 - 17:40	Precision oncology roadmap for colon cancer	Soonmyung Paik (Yonsei University)
17:40 - 18:00	Linking the genomic "Dark Matter" to precision cancer medicine via LncRNAs	Danny N. Dhanasekaran (University of Oklahoma)
18:00	Closing remark	Yong Sang Song (Seoul National University)

Time	Events	Chairs & Speakers
8:30 - 9:00	Registration
9:00 - 9:10	Opening Remark	Yong Sang Song (Seoul National University)
Session 11 - Chair: Masanobu Oshima (Kanazawa University)
9:10 - 9:30	Targeting mitochondria for preventing and treating cancer with natural compounds from food and nutrition	Jiankang Liu (Xi'an Jiaotong Unviersity School of Life Science)
9:30 - 9:50	Comprehensive phenotype characterization of intestinal tumors with various driver mutations	Masanobu Oshima (Kanazawa University)
9:50 - 10:10	Single Cell based Cancer Drug Screening	Duhee Bang (Yonsei University)
10:10 - 10:30	The Role of Plasma Gelsolin (pGSN) in Immune Cell Regulation in Ovarian Cancer Chemoresistance	Meshach Asare-Werehene (University of Ottawa)
10:30 - 10:50	Coffee break
Session 12 - Chair: Chin Kun Wang (Chung Shan Medical University)
10:50 - 11:10	Precision medicine on cancer treatment by using traditional herbs	Chin Kun Wang (Chung Shan Medical University)
11:10 - 11:30	Ascites-derived and tissue-derived ovarian cancer cell primary 3D cultures aimed for precision medicine	Yoshiko Nanki (Keio University School of Medicine)
11:30 - 11:50	Steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines	Yong Tae Kim (Yonsei University)
11:50 - 13:30	Lunch
Session 13 - Chiar: Seonwoo Kim (Samsung Medical Center)
13:30 - 13:50	Determining cutoff values of biomarkers	Seonwoo Kim (Samsung Medical Center)
13:50 - 14:10	Application of next-generation sequencing to identify genetic alterations associated with multi-step carcinogenesis in lung adenocarcinoma	Soyeon Ahn (Seoul National University Bundang Hospital)
14:10 - 14:30	TBD	Cheol-Min Kim (Pusan National University)
14:30 - 14:50	Coffee break
Session 14 - Chiar: Jungsoo Gim (Seoul National University)
14:50 - 15:10	Predicting multi-class response to preoperative chemoradiotherapy in rectal cancer patients	Jungsoo Gim (Seoul National University)
15:10 - 15:30	Deep learning based identification of cancer using gene expression data	Taejin Ahn (Handong Global University)
15:30 - 15:50	Systems biology application in cancer	Seungyoon Nam (Gachon University Gil Medical Center)
15:50 - 16:10	Coffee break
Session 15 - Chair: Toshikazu Ushijima (National Cancer Center Research Institute)
16:10 - 16:30	Precision cancer risk diagnosis reflecting life history	Toshikazu Ushijima (National Cancer Center Research Institute)
16:30 - 16:50	Identification and characterization of inhibitors targeting oncogenic tyrosine kinases	Zhizhuang Joe Zhao (University of Oklahoma Health Sciences Center)
16:50 - 17:10	Discovering Cancer Heterogeneity by Image Analysis-linked Genomics using Phenotype-based High-throughput Laser-aided Isolation and Sequencing (PHLI-seq)	Sunghoon Kwon (Seoul National Univeristy)
	Closing remark	Yong Sang Song (Seoul National University)

Time	Events	Chairs & Speakers
8:30 - 9:00	Registration
9:00 - 9:10	Opening Remark	Yong Sang Song (Seoul National University)
Session 16 - Chair: Manfred Schwab (German Cancer Research Center)
9:10 - 9:30	Co-Chaperone BAG2 Determines Pro-Oncogenic Role of Cathepsin B in Triple-Negative Breast Cancer Cells	Seong-Jin Kim (Seoul National University)
9:30 - 9:50	Decoding epigenome and developing nucleic-acid therapeutics in human cancers	Yutaka Kondo (Nagoya University Graduate School of Medicine)
9:50 - 10:10	Development of Web-based System to Integrate Multicenter Gynecologic Oncological Clinical Trial Data	Jinwook Choi (Seoul National University)
10:10 - 10:30	The impacts of the loss of the KRAS wild type allele to pancreatic tumorigenesis	Gloria H. Su (Columbia University Medical Center)
10:30 - 10:50	Coffee break
Session 17 - Chair: Jun Nishihira (Hokkaido Information University)
10:50 - 11:10	Proposal of ICT-assisted research platform to prevent life-style diseases including cancer by traditional functional foods	Jun Nishihira (Hokkaido Information University)
11:10 - 11:30	Overcoming gefitinib resistance in non-small-cell lung cancer by inducing Epidermal Growth Factor Receptor (EGFR) degradation via methionine 790 oxidation	Elaine Leung (Macau University of Science and Technology)
11:30 - 11:50	Chemoprevention of Esophageal squamous cell carcinoma	Kangdong Liu (Henan Cancer Hospital)
11:50 - 12:10	Precision Targeting of Pathologic Cdk5 Activity: A Key to Therapeutic Translation	John J. Leeterio (University Hospital's Seidman Cancer Center)
12:10 - 14:00	Lunch
Session 18 - Chair: Ciro Isidoro (Università del Piemonte Orientale)
14:00 - 14:20	Fighting cancer with Natural Epigenetic Modifiers: Autophagy as a target	Ciro Isidoro (Universit del Piemonte Orientale)
14:20 - 14:40	Transglutaminase is a mesothelioma cancer stem cell survival protein	Richard L. Eckert (University of Maryland School of Medicine and Greenbaum Cancer Center)
14:40 - 15:00	Human-Enzyme Mediated, Systemic Depletion of Amino Acids for Cancer Prevention and Treatment.	John DiGiovanni (University of Texas at Austin)
15:00 - 15:20	Coffee break
Session 19 - Chair: Massaoud Mirdhahi (Uinveriste Paris Dederot)
15:20 - 15:40	Fibrin deposit on the peritoneal surface serve as a niche for cancer expansion in carcinomatosis patients	Massaoud Mirdhahi (Uinveriste Paris Dederot)
15:40 - 16:00	Testing for genetic associations in arbitrarily structured populations	Minsun Song (Sookmyung Women's University)
16:00 - 16:20	Identifying miRNA-mRNA integration set associated with survival time of pancreatic ductal adenocarcinoma patients	Taesung Park (Seoul National University)
16:20 - 16:40	Coffee break
Session 20 - Chair: Taesung Park (Seoul National University)
16:40 - 17:00	Incorporating genetic network into case-control association studies with high-dimensional DNA methylation data	Hokeun Sun (Pusan National University)
17:00 - 17:20	Statistical methods to identify gene-gene interactions for binary traits through dimensional reduction	Mira Park (Eulji University)
17:20 - 17:40	Assembly Meeting of ISPCM	Benjamin K. Tsang (University of Ottawa)
17:40	Closing remark	Yong Sang Song (Seoul National University)